Injective vs QuarkChain — how do they compare? Injective trades at Rp92,698 (market cap Rp9,26T, Rp1,75T 24h volume), while QuarkChain trades at Rp35.24 (market cap Rp254,64M, Rp9,47M 24h volume). The key difference: Injective is far larger — about 36365.1× QuarkChain's market cap, and Injective's circulating supply is 100M INJ versus 7,3B QKC for QuarkChain. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and QuarkChain for 32 Days on average.
| INJ | QKC | |
|---|---|---|
Market Cap | Rp9,26T | Rp254,64M |
Volume (24h) | Rp1,75T | Rp9,47M |
Circulating Supply | 100M INJ | 7,3B QKC |
Typical Hold Time | 36 Days | 32 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
QuarkChain (QKC) is trading at Rp35.322 with a market cap of Rp255.3M, showing a bearish technical signal driven by moving averages, while oscillators remain neutral. The current price hovers near support at S1 (Rp35) with resistance at R1 (Rp38). No major protocol updates or ecosystem news were found recently, indicating limited fundamental catalysts.
Overall outlook is cautious due to bearish momentum and low market cap, which heightens volatility risks. Key opportunities include potential rebounds from support levels, but major risks involve thin liquidity and lack of recent development activity. Investors should monitor trading volume and network metrics for signs of renewed interest.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →The QuarkChain Network is a permissionless blockchain architecture that aims to meet global commercial standards. It aims to provide a secure, decentralized, and scalable blockchain solution to deliver 100,000+ on-chain TPS.
Read more on QKC →